+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds



Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds



Official Gazette of the United States Patent & Trademark Office Patents 1257(5), Apr 30



The present invention is directed to a method for treating dermal atrophy of the skin. The method of the invention includes applying a composition to the skin of a mammal suffering from dermal atrophy of the skin, and comprising at least one thyroid hormone compound or thyroid hormone-like compound together with a pharmacologically acceptable base suitable for topical application, wherein the thyroid hormone compound or the thyroid hormone-like compound binds to TR-alpha or TR-beta with an equilibrium dissociation constant, Kd, of at least 10-5 M. The invention is also directed to an article of manufacture comprising packaging material and a pharmaceutical agent contained within the packaging material, wherein the pharmaceutical agent is therapeutically effective for treating dermal atrophy of the skin.

(PDF emailed within 1 workday: $29.90)

Accession: 035980197

Download citation: RISBibTeXText


Related references

Thyroid hormone receptor isoform selectivity of thyroid hormone disrupting compounds quantified with an in vitro reporter gene assay. Environmental Toxicology and Pharmacology 23(3): 302-307, 2007

Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney. Toxicology 205(1-2): 95-102, 2004

Mechanistic analysis of metabolomics patterns in rat plasma during administration of direct thyroid hormone synthesis inhibitors or compounds increasing thyroid hormone clearance. Toxicology Letters 225(2): 240-251, 2014

Mechanistic explanation of different metabolomics patterns in rat plasma for the differentiation of direct thyroid hormone synthesis inhibitors and compounds increasing thyroid hormone clearance. Toxicology Letters 221: S193-S194, 2013

Endocrine disease: progress in diagnosis and treatment. Topics: II. Progress in treatment: 4. Thyroid hormone and lipid metabolism: novel thyroid hormone receptor beta1 selective thyroid hormone analogs. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 101(4): 1000-1006, 2012

Effect of surgical treatment on prolactin and thyroid stimulating hormone responsiveness to thyroid releasing hormone in patients with autonomous thyroid nodules. Acta Endocrinologica Supplementum (225): 38, 1979

Thyroid stimulating hormone receptor studies rationale for treatment of patients with multinodular goiter and differentiated thyroid tumors with thyroid hormone. Roeher, H -D And O H Clark (Ed ) Progress in Surgery, Vol 19 Thyroid Tumors Vii+227p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 181-204, 1988

Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease. Journal of Oncology 2016: 6496750, 2016

Receptors for thyrotropin-releasing hormone, thyroid-stimulating hormone, and thyroid hormones in the macaque uterus: effects of long-term sex hormone treatment. Menopause 19(11): 1253-1259, 2013

Tissue responses to thyroid hormone in a kindred with resistance to thyroid hormone harboring a commonly occurring mutation in the thyroid hormone receptor beta gene (P453T). Journal of Laboratory and Clinical Medicine 146(2): 85-94, 2005

Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone. Molecular Endocrinology 17(9): 1767-1776, 2003

Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid Cancer. Nuclear Medicine and Molecular Imaging 49(2): 115-121, 2015

Dna and thyroid hormone binding properties of a mutant thyroid hormone receptor c erba beta responsible for generalized thyroid hormone resistance gthr. Clinical Research 38(2): 474A, 1990

Fetal and neonatal iron deficiency exacerbates mild thyroid hormone insufficiency effects on male thyroid hormone levels and brain thyroid hormone-responsive gene expression. Endocrinology 155(3): 1157-1167, 2014

Severe thyroid atrophy due to prolonged ingestion of thyroid hormone for treatment of obesity. Southern Medical Journal 77(2): 268-270, 1984